US-based Iris Telehealth and Singapore-based Holmusk have entered a strategic partnership to enhance mental health care through data-driven insights.
The collaboration will integrate Holmusk’s NeuroBlu platform with Iris Insights to provide healthcare organisations with localised behavioural health data.
The partnership, which enables improved patient outcomes and value-based care, focuses on leveraging real-world data to identify at-risk patient populations.
By using advanced risk stratification, healthcare organisations can access these insights through an intuitive dashboard within the Iris Insights ecosystem.
The integration will support the development and evaluation of programmes that demonstrate improved outcomes and customer value.
Holmusk’s NeuroBlu AI platform will underpin predictive modelling and data-driven insights within Iris Insights.
The capability is crucial for health systems to expand behavioural health services while managing costs and enhancing clinical outcomes through localised insights.
Iris Telehealth CEO Andy Flanagan said: “This partnership with Holmusk represents a significant leap forward in our mission to transform behavioural healthcare delivery.
“By integrating Holmusk’s world-class NeuroBlu platform into our Iris Insights system, we’re empowering healthcare organisations with the real-world evidence and analytics they need to make informed decisions, improve patient outcomes, and build truly sustainable behavioural health programs.”
Iris Telehealth, using a network of licensed clinicians and data analytics, provides patient-centred, evidence-based care.
The company partners with healthcare organisations to deliver sustainable telepsychiatry and therapy programmes.
Based in New York, Holmusk offers real-world data, AI analytics, and digital solutions to advance the research and care in behavioural health.
The collaboration addresses the increasing demand for behavioural health services amidst clinician shortages and the need for measurable outcomes.
It supports healthcare leaders in building effective mental health programmes that meet community needs by offering actionable insights tailored to specific markets and populations.
Holmusk CEO Nawal Roy said: “This partnership brings together two complementary strengths – deep data science capabilities and direct clinical delivery – to drive meaningful innovation in behavioural health.
“Together, we’re creating new opportunities for healthcare organisations to demonstrate value while improving the lives of patients who need mental health support.”
